ストックスクリーナーアプリを入手
79.13
3.39%
2.5287
10 X Genomics Inc (TXG) 最新ニュース
Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancer - BioSpectrum Asia
Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know - Yahoo Finance
10x Genomics (TXG) CFO Adam Taich Sells 46,388 Shares - GuruFocus
10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com Nigeria
10x Genomics Inc (TXG) Shares Surge 3.3% -- What GF Score of 56 Tells Investors - GuruFocus
10x Genomics (TXG) CFO sells shares under preset trading plan - Stock Titan
10x Genomics CFO Adam Taich sells USD 2.99 million in common shares - Bitget
10x Genomics to Use Lunit’s AI-Powered Pathology Platform for Oncology Biomarker Discovery - GenomeWeb
AI will pair tissue scans with molecular maps in cancer studies - Stock Titan
10x genomics director Stuelpnagel sells $1.2 million in shares By Investing.com - Investing.com Australia
symbol__ Stock Quote Price and Forecast - CNN
10x Genomics (NASDAQ: TXG) executive plans multimillion-dollar stock sale - Stock Titan
10x Genomics Insider John R. Stuelpnagel Sells 20,000 Shares Between $60.66 and $62.61 on September 3, 2026 (NASDAQ: TXG) - kalkinemedia.com
10x Genomics stock hits 52-week high at 66.95 USD By Investing.com - Investing.com South Africa
Macrogen to offer 10x Genomics spatial biology platform in Asia first - Korea Biomedical Review
10x genomics director Stuelpnagel sells $1.2 million in shares - investing.com
10x Genomics Inc (TXG) Stock Up 4.7% but GF Value Says Overvalued -- GF Score: 56/100 - GuruFocus
10x Genomics (TXG) director offloads 20,000 shares in open-market trades - Stock Titan
T. Rowe Price reports 10%+ holding in 10x Genomics (TXG) - Stock Titan
Stifel reiterates Buy rating on 10X Genomics stock - investing.com
10X Genomics Inc (TXG) Key Financial Ratios – Valuation, Profitability & More - Value Research
10x Genomics (TXG) CEO holds 1,075,249 shares after 100-share gift - Stock Titan
Founder trust at 10x Genomics (NASDAQ: TXG) moves to sell 20,000 shares - Stock Titan
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead? - finance.yahoo.com
TXG Stock Price and Chart — NASDAQ:TXG - TradingView
A Look at 10x Genomics Inc (TXG) After 4.0% Decline -- GF Value $18.36 vs Price $60.00 - GuruFocus
RBC Capital initiates 10X Genomics stock with Sector Perform rating - investing.com
10X GENOMICS, INC. : RBC INITIATES COVERAGE WITH SECTOR PERFORM RATING; TARGET PRICE $70 - Bitget
Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit - Benzinga
TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences - TradingView
10X Genomics Inc (TXG) Peer Comparison – Compare with Others - Value Research
10x Genomics Wins Patent Infringement Verdict against Parse Biosciences - marketscreener.com
Delaware jury finds Parse infringed three genetic-sequencing patents - Reuters
TXG - Finviz
10x Genomics Inc (TXG) Shares Fall 5.1% -- GF Value Says Still O - GuruFocus
10x Genomics (TXG) CEO sells 10,486 shares under 10b5-1 plan - Stock Titan
10x Genomics wins jury award in Qiagen patent row (TXG:NASDAQ) - Seeking Alpha
10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences - Porterville Recorder
10x Genomics Inc (TXG) Director Shehnaaz Suliman Sells 2,207 Sha - GuruFocus
10x Genomics (NASDAQ: TXG) CEO sells for taxes, still holds 1,085,835 shares - Stock Titan
10x Genomics (NASDAQ: TXG) CEO lines up another share sale - Stock Titan
10x Genomics (NASDAQ: TXG) exec to sell 16,614 shares - Stock Titan
10x Genomics (NASDAQ: TXG) insider plans sale of 17,948 shares - Stock Titan
10x Genomics (NASDAQ: TXG) holder to sell about $871K in stock - Stock Titan
10x Genomics (TXG) CEO gifts 4,000 shares in stock donation - Stock Titan
10x Genomics: The Turnaround Is Real, But Atera Now Has To Deliver (Rating Upgrade) (TXG) - Seeking Alpha
Fed. Circ. Backs PTAB's Ax Of 10x Genomics Patent Claims - law360.com
Federal Circuit Upholds PTAB Obviousness Rulings Against Single Cell Sequencing Patents - IPWatchdog.com
10x Genomics Gains as Investors Extend Post-Earnings Rally on Atera Demand - Quiver Quantitative
10x Genomics’ Bid to Revive Patents Rejected by Federal Circuit - Bloomberg Law News
10x Genomics (NASDAQ:TXG) Reaches New 52-Week HighWhat's Next? - MarketBeat
10x Genomics stock hits 52-week high at $60.73 By Investing.com - Investing.com Australia
10x Genomics stock hits 52-week high at $60.73 - Investing.com
Bank of America Corp DE Has $20.48 Million Position in 10x Genomics $TXG - MarketBeat
Director Sarah Teichmann Sells 7,551 Shares of 10x Genomics Inc (TXG) - GuruFocus
10x Genomics (TXG) Sees Strong Early Orders for New Atera Platform - Yahoo Finance
A Look at 10x Genomics Inc (TXG) After 3.4% Gain -- GF Value $18 - GuruFocus
10x Genomics Inc (TXG) (Q2 2026) Earnings Call Highlights: Atera Launch Drives Record Demand Amidst Transition - GuruFocus
10x Genomics (NASDAQ: TXG) director sells under 10b5-1 plan - Stock Titan
7 Best Genomics Stocks for 2026 and How to Invest - The Motley Fool
10x Genomics (TXG) Could Be 35% Above Fair Value Following 2026 Outlook Lift - Yahoo Finance
0.01%
0.48%
大文字化:
|
ボリューム (24 時間):